LY-2940094 is primarily investigated for its potential therapeutic applications in the treatment of various psychiatric and neurological disorders. It functions as a nociceptin receptor antagonist, which makes it a promising candidate for addressing conditions like depression, anxiety, and substance abuse. By blocking the nociceptin receptor, it may help regulate mood and emotional responses, offering a novel approach to managing these disorders. Additionally, research suggests its potential in alleviating pain and reducing addictive behaviors, making it a compound of interest in both mental health and addiction treatment fields. Its development highlights ongoing efforts to find more effective and targeted therapies for complex brain-related conditions.